Novartis (NVS) reported $14.05 billion in revenue for the quarter ended June 2025, representing a year-over-year increase of 9.2$2.42 for the same period compares to $1.97 a year ago.The reported revenue represents a surprise of +0.13$14.04 billion. With the consensus EPS estimate being $2.38, the EPS surprise was +1.68%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their ...